DOI: https://doi.org/10.46880/methoda.Vol8No1.pp50-61
ABSTRACT
Candida species is an important cause of nosocomial infection that lead to death and
prolonged hospital stay. The number of immunocompromised patients, at greater risk of
fungal infection, treated in intensive care units (ICUs) has increased considerably. The
widespread use of invasive monitoring , therapeutic equipment and treatment with broad
spectrum antibiotic increases the risk of fungal colonization and infection. An acute
awareness of the increasing incidence of Candida as a pathogen and of the associated
morbidity and mortality is necessary. Guidelines management of candidiasis by Infectious
Disesase Society of America(IDSA) in 2009 previously, was revised. There have been new
data pertaining to diagnosis, prevention, and treatment for proven or suspected invasive
candidiasis, leading to significant modification in treatment recommendations, which
released in 2016. This article provides a summary of the most recent guideline for the
management of candidiasis.
Keywords: Candidia, Candidiasis, Nosocomial Infection, Intensive Care Units, Guidelines,
Treatment